| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | Interim CEO
2 companies
Quinn Anthony G. is a President &CEO at Spyre Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 22 buys and 0 sells.
Estimated insider holdings value: $41.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | GBIO Generation Bio Co. | Director | Buy | 210,791 | $0.96 | $203,209.36 | +69.6% | -59.3% | -38.8% | |
| Dec 1, 2023 | GBIO Generation Bio Co. | Director | Buy | 88,495 | $1.41 | $124,777.95 | New | +80.6% | +9.4% | |
| Mar 16, 2022 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 80,079 | $2.34 | $187,705.18 | +17.0% | -71.1% | -85.9% | |
| Mar 15, 2022 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 144,666 | $1.94 | $280,942.97 | +12.9% | -60.5% | -83.4% | |
| Dec 10, 2021 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 53,634 | $3.71 | $198,972.10 | +9.0% | -43.0% | -89.9% | |
| Apr 30, 2020 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 165,000 | $4.75 | $783,750.00 | +44.2% | - | - | |
| Jun 14, 2019 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 31,905 | $6.16 | $196,453.22 | +3.2% | - | - | |
| May 22, 2019 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 26,592 | $6.77 | $180,032.46 | +2.9% | - | - | |
| May 17, 2019 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 18,713 | $6.75 | $126,398.71 | +1.7% | - | - | |
| Aug 15, 2018 | SYRE Spyre Therapeutics, Inc. | President &CEO | Buy | 2,994 | $7.05 | $21,115.22 | +1.6% | - | - |